Tolerance Bio signs $560m worldwide TLB-33 deal with Tanabe Pharma
Tolerance Bio has signed an agreement securing an exclusive licence from Tanabe Pharma for TLB-33 in a deal of up to around $560m.
Read the full article on the original site.
Read Full Article